Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 4;34(2):1533317518802461.
doi: 10.1177/1533317518802461. Online ahead of print.

The Effectiveness of Reality Orientation Therapy in the Treatment of Parkinson Disease Dementia

Affiliations

The Effectiveness of Reality Orientation Therapy in the Treatment of Parkinson Disease Dementia

Carlos Henrique Ferreira Camargo et al. Am J Alzheimers Dis Other Demen. .

Abstract

Patients with Parkinson disease dementia (PDD) have deficits resulting mainly from frontostriatal dysfunction. The aim of this study was to assess the effectiveness of reality orientation therapy (ROT) combined with drug therapy (acetylcholinesterase inhibitors) in PDD treatment and compare it with that of drug therapy alone. Patients (n = 12) with a diagnosis of PDD were divided into 2 groups: group A-drug therapy and ROT; group B-drug therapy alone. Reality orientation therapy was applied weekly for 6 months, and patients were assessed during the same period. Significant improvements in frontostriatal deficits were observed in the group that received the combined therapy, as shown mainly by the scores in verbal fluency in the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) battery ( P = .02) and in attention in Scales for outcomes of Parkinson's Disease-Cognition ( P = .021) and Clock Drawing Test ( P = .037). Patients who received only medication had worse results in constructional praxis recall in the CERAD battery ( P = .037). Our results indicate that ROT may help in the treatment of frontostriatal cognitive deficits and can potentially be used to complement drug therapy.

Keywords: Parkinson disease; dementia; reality orientation therapy (ROT).

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) results for both groups.
Figure 2.
Figure 2.
Scales for Outcomes in Parkinson’s Disease–Cognition (SCOPA-Cog) results for both groups.
Figure 3.
Figure 3.
Clock Drawing Test (CDT) results for both groups.

References

    1. Goldman JG, Litvan I. Mild cognitive impairment in Parkinson’s disease. Minerva Med. 2011;102(6):441–459. - PMC - PubMed
    1. Leung IHK, Walton CC, Hallock H, Lewis SJG, Valenzuela M, Lampit A. Cognitive training in Parkinson disease: a systematic review and meta-analysis. Neurology. 2015;85(21):1843–1851. - PMC - PubMed
    1. Salat D, Noyce AJ, Schrag A, Tolosa E. Challenges of modifying disease progression in prediagnostic Parkinson’s disease. Lancet Neurol. 2016;15(6):1–12. doi:10.1016/S1474-4422(16)00060-0. - PubMed
    1. Poewe W. Non-motor symptoms in Parkinson’s disease. Eur J Neurol. 2008;15(Suppl 1):14–20. doi:10.1111/j.1468-1331.2008.02056.x. - PubMed
    1. Almaraz AC, Driver-Dunckley ED, Woodruff BK, et al. . Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia. Neurologist. 2009;15(4):234–237. - PubMed

LinkOut - more resources